Anti-RING2 / RING1B / RNF2 antibody (ab194666) at 5 µg/ml + Human stomach lysate at 50 µgdeveloped using the ECL technique
Anti-RING2 / RING1B / RNF2 antibody (ab194666) at 5 µg/ml + PC-12 cell lysate at 50 µgdeveloped using the ECL technique
Anti-RING2 / RING1B / RNF2 antibody (ab194666) at 5 µg/ml + HeLa S3 nuclear extract at 50 µgdeveloped using the ECL technique
Anti-RING2 / RING1B / RNF2 antibody (ab194666) at 5 µg/ml + Raw264.7 cell lysate at 50 µgdeveloped using the ECL technique
Anti-RING2 / RING1B / RNF2 antibody (ab194666) at 5 µg/ml + NIH/3T3 cell lysate at 50 µgdeveloped using the ECL technique
All lanes : Anti-RING2 / RING1B / RNF2 antibody (ab194666) at 5 µg/mlLane 1 : RING2 / RING1B / RNF2 transfected 293T cell lysateLane 2 : Non-transfected 293T cell lysateLysates/proteins at 15 µl per lane.developed using the ECL technique
Immunofluorescent analysis of HeLa cells labeling RING2 / RING1B / RNF2 with ab194666 at 10 µg/ml.